Abstract |
The present study was aimed to test the hypothesis that inorganic phosphate may reduce arsenic toxicity by decreasing its intestinal transference. Co-administration of inorganic phosphate (6.56 M) and arsenic (6.07 mM) in the intestinal loops of rats, in situ, caused significant reduction of arsenic transference. Short-term arsenic exposure (3mg/kg body weight/day for 30 days) caused liver damage evidenced by activities of liver enzymes and necroinflammatory changes. These effects of arsenic were coupled with enhanced mitochondrial swelling, inhibition of cytochrome c oxidase, Ca(2+)- ATPase, a decrease in mitochondrial calcium content, changes in indices of hepatic mitochondrial oxidative stress and iNOS expression. Arsenic also increased hepatic caspase 3 activity and DNA fragmentation. All these apoptosis-related molecular changes caused by arsenic could be alleviated by supplementation with inorganic phosphate, which likely suggests a protective role of phosphate against arsenic-induced hepatotoxic changes.
|
Authors | Sangita Majumdar, Subhra Karmakar, Anasuya Maiti, Monalisa Choudhury, Aniruddha Ghosh, Asankur Sekhar Das, Chandan Mitra |
Journal | Environmental toxicology and pharmacology
(Environ Toxicol Pharmacol)
Vol. 31
Issue 1
Pg. 107-18
(Jan 2011)
ISSN: 1872-7077 [Electronic] Netherlands |
PMID | 21787675
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 Elsevier B.V. All rights reserved. |
Chemical References |
- Phosphates
- Phosphorus, Dietary
- Poisons
- Nitric Oxide
- Hydroxyl Radical
- Catalase
- Nitric Oxide Synthase Type II
- Superoxide Dismutase
- Caspase 3
- Arsenic
|
Topics |
- Animals
- Arsenic
(antagonists & inhibitors, toxicity)
- Arsenic Poisoning
(metabolism)
- Caspase 3
(metabolism)
- Catalase
(metabolism)
- Chemical and Drug Induced Liver Injury
(pathology, prevention & control)
- DNA Fragmentation
(drug effects)
- Dietary Supplements
- Hydroxyl Radical
(metabolism)
- Intestinal Mucosa
(metabolism)
- Lipid Peroxidation
(drug effects)
- Liver
(pathology)
- Male
- Mitochondria, Liver
(drug effects, pathology)
- Mitochondrial Membranes
(drug effects)
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type II
(metabolism)
- Phosphates
(therapeutic use)
- Phosphorus, Dietary
(pharmacology)
- Poisons
(toxicity)
- Rats
- Rats, Wistar
- Superoxide Dismutase
(metabolism)
|